These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28171876)

  • 1. Clinical Value of the Epstein-Barr Virus and p16 Status in Patients with Nasopharyngeal Carcinoma: A Single-Centre Study in Japan.
    Saito Y; Ushiku T; Omura G; Yasuhara K; Yoshida M; Takahashi W; Ando M; Fukayama M; Yamasoba T
    ORL J Otorhinolaryngol Relat Spec; 2016; 78(6):334-343. PubMed ID: 28171876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of p16 expression in Epstein-Barr virus-positive nasopharyngeal carcinomas.
    Jiang W; Chamberlain PD; Garden AS; Kim BY; Ma D; Lo EJ; Bell D; Gunn GB; Fuller CD; Rosenthal DI; Beadle BM; Frank SJ; Morrison WH; El-Naggar AK; Glisson BS; Sturgis EM; Phan J
    Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E1459-66. PubMed ID: 26560893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus and human papillomaviruses as favorable prognostic factors in nasopharyngeal carcinoma: A nationwide study in Finland.
    Ruuskanen M; Irjala H; Minn H; Vahlberg T; Randen-Brady R; Hagström J; Syrjänen S; Leivo I
    Head Neck; 2019 Feb; 41(2):349-357. PubMed ID: 30549170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a non-endemic eastern european population.
    Svajdler M; Kaspirkova J; Mezencev R; Laco J; Torday T; Dubinsky P; Straka L; Ondic O; Michal M; Skalova A
    Neoplasma; 2016; 63(1):107-14. PubMed ID: 26639240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.
    Rosales-Pérez S; Cano-Valdez AM; Flores-Balcázar CH; Guedea-Edo F; Lino-Silva LS; Lozano-Borbalas A; Navarro-Martín A; Poitevin-Chacón A
    Arch Med Res; 2014 Apr; 45(3):229-36. PubMed ID: 24606815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of human papillomavirus on nasopharyngeal carcinoma in Japan.
    Kano M; Kondo S; Wakisaka N; Moriyama-Kita M; Nakanishi Y; Endo K; Murono S; Nakamura H; Yoshizaki T
    Auris Nasus Larynx; 2017 Jun; 44(3):327-332. PubMed ID: 27499435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programmed Death-Ligand 1 Expression, Microsatellite Instability, Epstein-Barr Virus, and Human Papillomavirus in Nasopharyngeal Carcinomas of Patients from the Philippines.
    Chang AMV; Chiosea SI; Altman A; Pagdanganan HA; Ma C
    Head Neck Pathol; 2017 Jun; 11(2):203-211. PubMed ID: 27807760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus and human papillomavirus serum antibodies define the viral status of nasopharyngeal carcinoma in a low endemic country.
    Simon J; Schroeder L; Ingarfield K; Diehl S; Werner J; Brenner N; Liu Z; Pawlita M; Pring M; Butt J; Ness A; Waterboer T
    Int J Cancer; 2020 Jul; 147(2):461-471. PubMed ID: 32279316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral markers in nasopharyngeal carcinoma: A systematic review and meta-analysis on the detection of p16
    Tham T; Machado R; Russo DP; Herman SW; Teegala S; Costantino P
    Am J Otolaryngol; 2021; 42(1):102762. PubMed ID: 33202328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus (EBV) and polyomaviruses are detectable in oropharyngeal cancer and EBV may have prognostic impact.
    Carpén T; Syrjänen S; Jouhi L; Randen-Brady R; Haglund C; Mäkitie A; Mattila PS; Hagström J
    Cancer Immunol Immunother; 2020 Aug; 69(8):1615-1626. PubMed ID: 32314041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma.
    Ruuskanen M; Leivo I; Minn H; Vahlberg T; Haglund C; Hagström J; Irjala H
    BMC Cancer; 2019 Jun; 19(1):624. PubMed ID: 31238894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a low-incidence population.
    Dogan S; Hedberg ML; Ferris RL; Rath TJ; Assaad AM; Chiosea SI
    Head Neck; 2014 Apr; 36(4):511-6. PubMed ID: 23780921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosis.
    Stenmark MH; McHugh JB; Schipper M; Walline HM; Komarck C; Feng FY; Worden FP; Wolf GT; Chepeha DB; Prince ME; Bradford CR; Mukherji SK; Eisbruch A; Carey TE
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):580-8. PubMed ID: 24521676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of oncogenic human papilloma virus and Epstein-Barr virus prevalence in Turkish nasopharyngeal cancer patients.
    Tatlı Doğan H; Kılıçarslan A; Doğan M; Süngü N; Güler Tezel G; Güler G
    Pathol Res Pract; 2016 Nov; 212(11):1021-1026. PubMed ID: 27640103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Epstein-Barr virus and human papillomavirus infection on macrophage migration inhibitory factor and macrophage polarization in nasopharyngeal carcinoma.
    Feng G; Xu Y; Ma N; Midorikawa K; Oikawa S; Kobayashi H; Nakamura S; Ishinaga H; Zhang Z; Huang G; Takeuchi K; Murata M
    BMC Cancer; 2021 Aug; 21(1):929. PubMed ID: 34407796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis.
    Zhang W; Zeng Z; Zhou Y; Xiong W; Fan S; Xiao L; Huang D; Li Z; Li D; Wu M; Li X; Shen S; Wang R; Cao L; Tang K; Li G
    Acta Biochim Biophys Sin (Shanghai); 2009 May; 41(5):414-28. PubMed ID: 19430707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival analysis of patients with advanced-stage nasopharyngeal carcinoma according to the Epstein-Barr virus status.
    Peng H; Chen L; Zhang Y; Guo R; Li WF; Mao YP; Tan LL; Sun Y; Zhang F; Liu LZ; Tian L; Lin AH; Ma J
    Oncotarget; 2016 Apr; 7(17):24208-16. PubMed ID: 27008701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment Serum Amyloid A and C-reactive Protein Comparing with Epstein-Barr Virus DNA as Prognostic Indicators in Patients with Nasopharyngeal Carcinoma: A Prospective Study.
    Chen QY; Tang QN; Tang LQ; Chen WH; Guo SS; Liu LT; Li CF; Li Y; Liang YJ; Sun XS; Guo L; Mo HY; Sun R; Luo DH; Fan YY; He Y; Chen MY; Cao KJ; Qian CN; Guo X; Mai HQ
    Cancer Res Treat; 2018 Jul; 50(3):701-711. PubMed ID: 28707462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of serum Epstein-Barr virus antibodies in patients with nasopharyngeal carcinoma and undetectable pretreatment Epstein-Barr virus DNA.
    Yao JJ; Lin L; Jin YN; Wang SY; Zhang WJ; Zhang F; Zhou GQ; Cheng ZB; Qi ZY; Sun Y
    Cancer Sci; 2017 Aug; 108(8):1640-1647. PubMed ID: 28603915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus 16 detected in nasopharyngeal carcinomas in white Americans but not in endemic Southern Chinese patients.
    Lin Z; Khong B; Kwok S; Cao H; West RB; Le QT; Kong CS
    Head Neck; 2014 May; 36(5):709-14. PubMed ID: 23616441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.